Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2014/08/004813
CTRI/2014/08/004813
Recruiting
N/A

A retrospective study of outcome in children with Kerosene consumption

Father Muller Medical College0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Children below 5 years admitted with Kerosene consumption

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: null- Children below 5 years admitted with Kerosene consumption
Sponsor
Father Muller Medical College
Enrollment
50
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Father Muller Medical College

Eligibility Criteria

Inclusion Criteria

  • •Children below 5 years admitted in Fr Muller Medical College Hospital with Kerosene consumption from April 2010 to March 2013

Exclusion Criteria

  • •Children above 5 years with kerosene consumption

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
A retrospective study of the outcome of children with neuroblastoma after relapse. the Japan neuroblastoma study group.neuroblastoma
JPRN-UMIN000004198Japan Neuroblastoma study group125
Recruiting
N/A
A Comparative clinical outcome study of Children with Severe Pneumonia at KCMH and ASIAN PICU(PACCMAN)severe pneumonia in children
TCTR20210929008/A100
Active, Not Recruiting
Phase 1
Follow-Up study in Previously Treated Children to investigate a new FVIII concentrate
EUCTR2011-001785-17-PLOctapharma AG50
Active, Not Recruiting
Phase 1
Follow-Up study in Previously Treated Children to investigate a new FVIII concentrateSevere Haemophilia AMedDRA version: 14.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2011-001785-17-CZOctapharma AG60
Active, Not Recruiting
Phase 1
Follow-Up study in Previously Treated Children to investigate a new FVIII concentrateSevere Haemophilia AMedDRA version: 14.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2011-001785-17-FROctapharma AG60